<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-id journal-id-type="pmc">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34413689</article-id>
      <article-id pub-id-type="pmc">8369225</article-id>
      <article-id pub-id-type="publisher-id">310698</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S310698</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Relationships Between a Range of Inflammatory Biomarkers and Subjective Sleep Quality in Chronic Insomnia Patients: A Clinical Study</article-title>
        <alt-title alt-title-type="running-authors">Xia et al</alt-title>
        <alt-title alt-title-type="running-title">Xia et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Xia</surname>
            <given-names>Lan</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="ft0001">*</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3884-2337</contrib-id>
          <name>
            <surname>Zhang</surname>
            <given-names>Ping</given-names>
          </name>
          <xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
          <xref ref-type="author-notes" rid="ft0001">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Niu</surname>
            <given-names>Jing-Wen</given-names>
          </name>
          <xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ge</surname>
            <given-names>Wei</given-names>
          </name>
          <xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7482-4094</contrib-id>
          <name>
            <surname>Chen</surname>
            <given-names>Jun-Tao</given-names>
          </name>
          <xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9866-8820</contrib-id>
          <name>
            <surname>Yang</surname>
            <given-names>Shuai</given-names>
          </name>
          <xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Su</surname>
            <given-names>Ai-Xi</given-names>
          </name>
          <xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7049-1149</contrib-id>
          <name>
            <surname>Feng</surname>
            <given-names>Yi-Zhou</given-names>
          </name>
          <xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Fang</given-names>
          </name>
          <xref ref-type="aff" rid="aff0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5102-8909</contrib-id>
          <name>
            <surname>Chen</surname>
            <given-names>Gong</given-names>
          </name>
          <xref ref-type="aff" rid="aff0004">
<sup>4</sup>
</xref>
          <xref ref-type="corresp" rid="an0002"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Chen</surname>
            <given-names>Gui-Hai</given-names>
          </name>
          <xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
          <xref ref-type="corresp" rid="an0001"/>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Department of Neurology, The Second Affiliated Hospital of Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0002"><label>2</label><institution>Department of Neurology (Sleep Disorders), The Affiliated Chaohu Hospital of Anhui Medical University</institution>, <addr-line>Hefei (Chaohu)</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0003"><label>3</label><institution>Department of Neurology, The First Affiliated Hospital of Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0004"><label>4</label><institution>Hefei Technology College</institution>, <addr-line>Hefei (Chaohu)</addr-line>, <country>People’s Republic of China</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Gui-Hai Chen <institution>Department of Neurology (Sleep Disorders), The Affiliated Chaohu Hospital of Anhui Medical University</institution>, <addr-line>Hefei (Chaohu)</addr-line>, <country>People’s Republic of China</country><phone>Tel/Fax +86-551-82321571</phone> Email doctorcgh@163.com</corresp>
        <corresp id="an0002">Gong Chen <institution>Hefei Technology College</institution>, <addr-line>Hefei (Chaohu)</addr-line>, <country>People’s Republic of China</country><phone>Tel +86-551-82367072</phone><fax>Fax +86-551-82351650</fax> Email ch_gong@163.com</corresp>
        <fn id="ft0001">
          <label>*</label>
          <p><citation_analysis attribute="neither">These authors contributed equally to this work</citation_analysis></p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>8</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>13</volume>
      <fpage>1419</fpage>
      <lpage>1428</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>3</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>7</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2021 Xia et al.</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Xia et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="s2001">
          <title>Purpose</title>
          <p><citation_analysis attribute="positive">To examine whether associations exist between chronic insomnia disorder (CID) and overlooked inflammatory factors (Serum amyloid protein A [SAA]), tumor necrosis factor [TNF]-α, granulocyte-macrophage colony-stimulating factor [GM-CSF], and regulated on activation and normal T cell expressed and presumably secreted [RANTES]).</citation_analysis></p>
        </sec>
        <sec id="s2002">
          <title>Patients and Methods</title>
          <p><citation_analysis attribute="neither">A total of 65 CID patients and 39 sex- and age-matched good sleeper (GS) controls participated in this study. They completed a baseline survey to collect data on demographics, and were elevated sleep and mood by Pittsburgh Sleep Quality Index (PSQI), Athens Insomnia Scale (AIS), 17-item Hamilton Depression Rating Scale (HAMD-17) and 14-item Hamilton Anxiety Rating Scale (HAMA-14), respectively. The blood samples were collected and tested the serum levels of SAA, TNF-α, GM-CSF and RANTES.</citation_analysis></p>
        </sec>
        <sec id="s2003">
          <title>Results</title>
          <p><citation_analysis attribute="neither">The CID group had higher serum levels of SAA, TNF-α, and GM-CSF and a lower level of RANTES than the GS group. In the Spearman correlation analysis, SAA and GM-CSF positively correlated with the PSQI and AIS scores. After controlling for sex, HAMD-17 score, and HAMA-14 score, the partial correlation analysis showed that GM-CSF was positively correlated with PSQI score. Further stepwise linear regression analyses showed that GM-CSF was positively associated with the PSQI and AIS scores, while RANTES was negatively associated with them, and SAA was positively associated with just the AIS score.</citation_analysis></p>
        </sec>
        <sec id="s2004">
          <title>Conclusion</title>
          <p><citation_analysis attribute="positive">The serum levels of inflammatory mediators (SAA, TNF-α, and GM-CSF) were significantly elevated and the level of RANTES was significantly decreased in CID patients and, to some extent, the changes are related to the severity of insomnia. These findings may help us to improve interventions to prevent the biological consequences of CID by inhibiting inflammation, thereby promoting health.</citation_analysis></p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>chronic insomnia disorder</kwd>
        <kwd>serum amyloid protein A; tumor necrosis factor (TNF)-α</kwd>
        <kwd>granulocyte-macrophage colony-stimulating factor</kwd>
        <kwd>regulated on activation and normal T cell expressed and presumably secreted</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution>the National Natural Science Foundation of China</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution>the Natural Science Foundation of Anhui Medical University</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
        <funding-statement>This work was financially supported by the National Natural Science Foundation of China (81671316), and the Natural Science Foundation of Anhui Medical University (2018xkj066).</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="14"/>
        <ref-count count="57"/>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">In the general population, about a third of individuals have sleep complaints, and nearly 10% fulfill the diagnostic criteria for chronic insomnia disorder (CID).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="negative"> CID has a strong impact on quality of life and is a risk factor for the development of other disorders, including psychological disease,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> cardiovascular disease,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> diabetes,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither"> certain cancers,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither"> obesity,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="positive"> and functional decline. This has substantial public health implications. In recent years, sleep research has increasingly focused on the biological mechanisms underlying these associations between insomnia and somatic diseases,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8–10</xref></citation_analysis><citation_analysis attribute="neither"> with substantial attention on the effect of chronic sleep loss on inflammation.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Compelling evidence has demonstrated that sleep disturbance (defined as difficulty initiating or maintaining sleep) and shorter sleep duration are associated with elevated inflammatory biomarkers, which may be linked to increased risk of chronic diseases.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11–13</xref></citation_analysis><citation_analysis attribute="positive"> A systematic review and meta-analysis of 72 studies (n &gt; 50,000) examined associations between insomnia and the proinflammatory markers interleukin (IL)-6 and the acute-phase protein C-reactive protein (CRP).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="positive"> The results showed that insomnia assessed based on self-reported symptoms was associated with higher levels of IL-6 but not CRP, while insomnia assessed by questionnaire was associated with higher levels of both IL-6 and CRP.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> However, other studies found that insomnia symptoms were associated with elevated CRP but not IL-6 in young adults.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="positive"> Other inflammatory factors that have frequently been explored in insomnia are tumor necrosis factor (TNF)-α and IL-1β, with associations between elevated levels and poor sleep quality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17–20</xref></citation_analysis><citation_analysis attribute="positive"> However, several other studies have shown no associations of insomnia with TNF-α and IL-1β.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="positive"> In brief, previous studies on insomnia and inflammation have predominantly focused on CRP, IL-6, TNF-α, and IL-1β, with slightly varying findings. These varying findings may be a result of inconsistent assessment of insomnia symptoms and different age group compositions. Importantly, the changes in other kinds of inflammatory factors remain unclear. To fill this knowledge gap, examining insomnia–inflammation associations based on a range of inflammatory biomarkers is warranted.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Inflammatory factors include ILs, colony-stimulating factors, TNFs, and chemokines.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither"> Granulocyte-macrophage colony-stimulating factor (GM-CSF) is best viewed as a major regulator governing the functions of granulocyte and macrophage lineage populations at all stages of maturation, playing a key role in inflammation.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> There is a mutual dependence between GM-CSF activity and monocyte or macrophage-derived proinflammatory cytokine activity, such as IL-1 and TNF-α activity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> Regulated on activation and normal T cell expressed and presumably secreted (RANTES; also known as C-C motif chemokine ligand 5 [CCL5]) is a chemokine.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="positive"> IL-1β has been shown to upregulate RANTES and GM-CSF mRNA in all fibroblast lines.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither"> TNF-α and IL-1β were found to be altered in insomnia patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17–20</xref></citation_analysis><citation_analysis attribute="neither"> However, there is no research on the changes in GM-CSF and RANTES in insomnia patients. In addition, acute-phase proteins are blood proteins that can be used to assess inflammation. These proteins undergo changes in their serum concentrations by &gt;25% in response to proinflammatory cytokine release during disease processes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> Serum amyloid protein A (SAA) and CRP are the most prominent members of the acute-phase response. SAA gene transcription is mainly induced by lipopolysaccharide and cytokines, including IL-6, IL-1, and TNF-α; the most prominent proinflammatory activities of SAA include the induction of the synthesis of pro-IL-1β.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="positive"> SAA has been implicated in several chronic inflammatory diseases, such as rheumatoid arthritis and cardiovascular disease,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="positive"> and a study reported elevated SAA in the plasma of patients with clinical depression relative to healthy controls.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="neither"> The changes in SAA in patients with CID have not been explored.</citation_analysis></p>
      <p><citation_analysis attribute="positive">In this study, we sought to examine whether associations exist between insomnia and the overlooked inflammatory factors (SAA, TNF-α, GM-CSF, and RANTES), to further understand the changes in inflammatory factors in CID patients.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Patients and Methods</title>
      <sec id="s0002-s2001">
        <title>Sample and Ethics Approval</title>
        <p><citation_analysis attribute="neither">Sixty-five patients (27 males and 38 females) with CID were recruited over a 6-month period from the Clinic of Sleep Disorder at the Affiliated Chaohu Hospital of Anhui Medical University. The CID patients had a mean age of 41.4±12.1 years (range, 18 to 60). The inclusion criteria were as follows: 1) complaints of sleep difficulty with enough time and proper environment for sleep accompanied by impairment of daytime functions; and 2) diagnosed based on the International Classification of Sleep Disorders (Third Edition) criteria,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither"> all the participants met criterion as listed in the ICSD-3 insomnia definition. The exclusion criteria were as follows: 1) taking antidepressants, antipsychotics, hypnotics and antibiotics within 2 weeks; 2) noncooperation or unable to complete the questionnaires due to vision and hearing impairment; 3) chronic inflammatory diseases, organic brain diseases, drug abuse, or other serious medical conditions; 4) comorbid with other mental disorders; and 5) pregnant or lactating. Thirty-nine good sleeper (GS) controls with no sleep or mood complaints and similar medical history were recruited from the Center of Health Examination in the same hospital during the corresponding period in order to reduce the differences in regions and study period. Good sleepers (19 males and 20 females) had a mean age of 42.2±14.3 years, with </citation_analysis><citation_analysis attribute="positive"><underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=310698.docx">Pittsburgh Sleep Quality Index (PSQI</ext-link></underline></citation_analysis><citation_analysis attribute="neither">) score &lt; 7, </citation_analysis><citation_analysis attribute="positive"><underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=310698.docx">Athens Insomnia Scale (AIS</ext-link></underline></citation_analysis><citation_analysis attribute="neither">) score &lt; 4, 17-item </citation_analysis><citation_analysis attribute="positive"><underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=310698.docx">Hamilton Depression Rating Scale (HAMD-17</ext-link></underline></citation_analysis><citation_analysis attribute="neither">) score &lt; 7, and 14-item </citation_analysis><citation_analysis attribute="positive"><underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=310698.docx">Hamilton Anxiety Rating Scale (HAMA-14</ext-link></underline></citation_analysis><citation_analysis attribute="positive">) score &lt; 7. The study was conducted in accordance with the Declaration of Helsinki, and it was approved by the Ethics Committee of the Affiliated Chaohu Hospital of Anhui Medical University. All subjects provided signed informed consent before study commencement.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Data Collection</title>
        <sec id="s0002-s2002-s3001">
          <title>Baseline Data Collection</title>
          <p><citation_analysis attribute="positive">We chose the appropriate assessment scales from our preliminary experiments. Before the beginning of the study, all the researchers were well trained to be familiar with the whole process of the survey and the instruction of the scale, and the standard of evaluation was unified, in order to ensure the consistency of methods of data collection and scales assessment. Demographic data, including sex, age, illness duration, and education level, were collected. HAMD-17 and HAMA-14 were used to evaluate depression and anxiety, respectively, as they are the most frequently used scales for this purpose. Sleep quality was assessed by PSQI and AIS. PSQI is a standard scale assessing sleep quality based on recalling sleep behaviors in the past month, consisting of subjective sleep quality, sleep latency, sleep duration, sleep efficiency, somnipathy, use of hypnotic drugs, and diurnal dysfunction.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="neither"> The total score ranges from 0 to 21 and, in China, a score ≥ 7 has high diagnostic sensitivity and specificity for distinguishing patients with poor sleep from normal subjects.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="neither"> AIS was modified in 2000 according to the International Classification of Diseases (ICD)-10 system.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="positive"> It is used to assess sleep quality in the prior month, and is suitable for evaluating sleep quality and monitoring treatment effects in patients with sleep disorders and mental disorders. There are eight items on the scale: sleep onset, night and early-morning waking, sleep time, sleep quality, frequency and duration of complaints, distress caused by the experience of insomnia, and interference with daily functioning. Each item is rated from 0 to 3, and the total score ranges from 0 to 24, and the score ≥ 6 being classified as insomnia. The higher the score, the worse the sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis></p>
        </sec>
        <sec id="s0002-s2002-s3002">
          <title>Serum Levels of TNF-α, RANTES, SAA, and GM-CSF</title>
          <p><citation_analysis attribute="positive">Elbow intravenous blood was collected between 7:00 and 9:00 a.m., with fasting and avoidance of strenuous activity and mental stimulation. The samples were separated immediately by centrifugation and the serum was frozen at –80°C. The serum levels of TNF-α, RANTES, SAA, and GM-CSF were assessed using a RayBiotech Chip Detection Test (Peachtree Corners, GA, USA) according to the manufacturer’s instructions by the simultaneous processing at last. All the samples were tested twice and got the average when the results were similar; otherwise, they would be retested and calculated again in order to reduce the test error.</citation_analysis></p>
        </sec>
      </sec>
      <sec id="s0002-s2003">
        <title>Statistical Analysis</title>
        <p><citation_analysis attribute="positive">We checked and reviewed the data carefully and chose the correct statistical analysis methods. Statistical analyses were performed using IBM SPSS Statistics version 22.0 software (SPSS, Chicago, IL). Extreme values were deleted if they were higher than “mean + 3 SD” or lower than “mean – 3 SD”. The data were then assessed using normality plots. Normally distributed data are expressed as mean ± standard deviation, and differences between groups were assessed using </citation_analysis><citation_analysis attribute="positive"><italic>t</italic></citation_analysis><citation_analysis attribute="positive">-tests. Non-normally distributed data are expressed as P50 (P25, P75), differences between groups were assessed using Mann–Whitney </citation_analysis><citation_analysis attribute="positive"><italic>U</italic></citation_analysis><citation_analysis attribute="positive">-tests and the chi-square test was used to compare sex differences between groups. In order to discriminate between confounding factors and their influence, Spearman correlation analysis, partial correlation analysis, and stepwise linear regression were used to explore the associations between the serum levels of inflammatory factors and the sleep quality. In addition, receiver operating characteristics (ROC) analysis was performed to compare the diagnostic information provided by different inflammatory factors, according to the calculated area under the curve (AUC), optimal cut-off points, sensitivity, and specificity. The AUCs at 0.9 indicated that these inflammatory factors had high diagnostic value. Two-tailed </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">&lt;0.05 was considered to be statistically significant.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <sec id="s0003-s2001">
        <title>Baseline Characteristics</title>
        <p><citation_analysis attribute="positive">There were no significant differences in age (</citation_analysis><citation_analysis attribute="positive"><italic>t</italic></citation_analysis><citation_analysis attribute="neither"> = 0.299, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.766), sex (</citation_analysis><citation_analysis attribute="positive"><italic>χ</italic></citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> = 0.509, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.475), or education level (</citation_analysis><citation_analysis attribute="positive"><italic>Z</italic></citation_analysis><citation_analysis attribute="neither"> = 0.306, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.760) between the CID and GS groups. The PSQI, AIS, HAMD-17, and HAMA-14 scores were significantly higher in the CID group than the GS group (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Demographic and Clinical Characteristics of Participants</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">CID</th><th rowspan="1" colspan="1">GS</th><th rowspan="1" colspan="1">Statistic</th><th rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Number</td><td rowspan="1" colspan="1">65</td><td rowspan="1" colspan="1">39</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sex (female, n, %)</td><td rowspan="1" colspan="1">22, 58.5%</td><td rowspan="1" colspan="1">19, 51.3%</td><td rowspan="1" colspan="1"><italic>χ</italic><sup>2</sup> = 0.509</td><td rowspan="1" colspan="1">0.475</td></tr><tr><td rowspan="1" colspan="1">Age (yr)</td><td rowspan="1" colspan="1">41.37 ± 12.12</td><td rowspan="1" colspan="1">42.15 ± 14.28</td><td rowspan="1" colspan="1"><italic>t</italic> = 0.299</td><td rowspan="1" colspan="1">0.766</td></tr><tr><td rowspan="1" colspan="1">Education (yr)</td><td rowspan="1" colspan="1">12.00 (9.00, 16.00)</td><td rowspan="1" colspan="1">15.00 (9.00, 16.00)</td><td rowspan="1" colspan="1"><italic>z</italic> = 0.306</td><td rowspan="1" colspan="1">0.760</td></tr><tr><td rowspan="1" colspan="1">PSQI (score)</td><td rowspan="1" colspan="1">14.97 ± 2.90*</td><td rowspan="1" colspan="1">2.00 (1.00, 3.00)</td><td rowspan="1" colspan="1"><italic>z</italic> = 8.539</td><td rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td rowspan="1" colspan="1">AIS (score)</td><td rowspan="1" colspan="1">14.55 ± 4.11*</td><td rowspan="1" colspan="1">0.00 (0.00, 1.00)</td><td rowspan="1" colspan="1"><italic>z</italic> = 8.603</td><td rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td rowspan="1" colspan="1">HAMD-17 (score)</td><td rowspan="1" colspan="1">10.40 ± 3.87*</td><td rowspan="1" colspan="1">3.00 (1.00, 5.00)</td><td rowspan="1" colspan="1"><italic>z</italic> = 8.068</td><td rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td rowspan="1" colspan="1">HAMA-14 (score)</td><td rowspan="1" colspan="1">10.71 ± 5.84*</td><td rowspan="1" colspan="1">0.00 (0.00, 2.00)</td><td rowspan="1" colspan="1"><italic>z</italic> = 8.136</td><td rowspan="1" colspan="1">&lt; 0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are expressed as mean ± SD (normally distributed variables) or P50 (P25, P75) (non-normally distributed variables). Compared to the GS group, *</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05.</citation_analysis></p></fn><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: CID, chronic insomnia disorder; GS, good sleeper; PSQI, Pittsburgh Sleep Quality Index; AIS, Athens Insomnia Scale; HAMD-17, 17-item Hamilton Depression Rating Scale; HAMA-14, 14-item Hamilton Anxiety Rating Scale.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0003-s2002">
        <title>TNF-α, RANTES, SAA, and GM-CSF Levels</title>
        <p><citation_analysis attribute="neither">Compared to the GS group, the serum levels of TNF-α, SAA, and GM-CSF were significantly higher in the CID group, while the RANTES level was lower (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05, </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2</label><caption><p><citation_analysis attribute="neither">TNF-α, RANTES, SAA and GM-CSF Levels in Participants</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">CID</th><th rowspan="1" colspan="1">GS</th><th rowspan="1" colspan="1">Statistic</th><th rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Number</td><td rowspan="1" colspan="1">65</td><td rowspan="1" colspan="1">39</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">TNF-α (pg/mL)</td><td rowspan="1" colspan="1">427.41 ± 203.60**</td><td rowspan="1" colspan="1">322.51 ± 117.74</td><td rowspan="1" colspan="1"><italic>t</italic> = 3.188</td><td rowspan="1" colspan="1">0.002</td></tr><tr><td rowspan="1" colspan="1">RANTES (ng/mL)</td><td rowspan="1" colspan="1">4.30 ± 0.62*</td><td rowspan="1" colspan="1">4.60 ± 0.72</td><td rowspan="1" colspan="1"><italic>t</italic> = 2.180</td><td rowspan="1" colspan="1">0.032</td></tr><tr><td rowspan="1" colspan="1">SAA (ng/mL)</td><td rowspan="1" colspan="1">53.50 (32.89, 72.47)**</td><td rowspan="1" colspan="1">28.31 (19.30, 38.71)</td><td rowspan="1" colspan="1"><italic>z</italic> = 4.575</td><td rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td rowspan="1" colspan="1">GM-CSF (pg/mL)</td><td rowspan="1" colspan="1">152.00 ± 49.62**</td><td rowspan="1" colspan="1">113.18 ± 40.02</td><td rowspan="1" colspan="1"><italic>t</italic> = 4.142</td><td rowspan="1" colspan="1">&lt; 0.001</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Data are expressed as mean ± SD (normally distributed variables) or P50 (P25, P75) (non-normally distributed variables). Compared to the GS group, *</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05, **</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01.</citation_analysis></p></fn><fn id="tfn0004"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: CID, chronic insomnia disorder; GS, good sleeper; TNF-α, tumor necrosis factor-α; RANTES, regulated on activation and normal T cell expressed and presumably secreted; SAA, serum amyloid protein A; GM-CSF, granulocyte-macrophage colony-stimulating factor.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0003-s2003">
        <title>Correlations of RANTES, SAA, GM-CSF, and TNF-α with Mood</title>
        <p><citation_analysis attribute="neither">In the Spearman correlation analyses, sex, the PSQI score, the AIS score and the serum levels of SAA and GM-CSF were positively correlated with the HAMD-17 and HAMA-14 scores (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05), and the TNF-α serum level was also positively correlated with the HAMD-17 score (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05). After controlling for sex, PSQI, and AIS scores, the partial correlation analyses showed that there was no relationship between the serum levels of inflammatory factors (SAA, TNF-α, GM-CSF, and RANTES) and the HAMD-17 and HAMA-14 scores (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &gt; 0.05). Furthermore, the linear regression method by stepwise showed that HAMD-17 and HAMA-14 scores were positively associated with the AIS score (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05). HAMD-17 score was also positively associated with PSQI score (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05, see </citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Correlations of RANTES, SAA, GM-CSF, and TNF-α with Mood</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Analysis</th><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">Sex</th><th rowspan="1" colspan="1">Age</th><th rowspan="1" colspan="1">Education</th><th rowspan="1" colspan="1">PSQI</th><th rowspan="1" colspan="1">AIS</th><th rowspan="1" colspan="1">TNF-α</th><th rowspan="1" colspan="1">RANTES</th><th rowspan="1" colspan="1">SAA</th><th rowspan="1" colspan="1">GM-CSF</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">Spearman correlation (<italic>r</italic>)</td><td rowspan="1" colspan="1">HAMD-17</td><td rowspan="1" colspan="1">0.208*</td><td rowspan="1" colspan="1">−0.013</td><td rowspan="1" colspan="1">−0.073</td><td rowspan="1" colspan="1">0.795**</td><td rowspan="1" colspan="1">0.800**</td><td rowspan="1" colspan="1">0.256*</td><td rowspan="1" colspan="1">−0.010</td><td rowspan="1" colspan="1">0.376**</td><td rowspan="1" colspan="1">0.308**</td></tr><tr><td rowspan="1" colspan="1">HAMA-14</td><td rowspan="1" colspan="1">0.235*</td><td rowspan="1" colspan="1">−0.013</td><td rowspan="1" colspan="1">−0.115</td><td rowspan="1" colspan="1">0.770**</td><td rowspan="1" colspan="1">0.847**</td><td rowspan="1" colspan="1">0.196</td><td rowspan="1" colspan="1">−0.105</td><td rowspan="1" colspan="1">0.432**</td><td rowspan="1" colspan="1">0.290**</td></tr><tr><td rowspan="2" colspan="1">Partial correlation (<italic>r</italic>)<sup>a</sup></td><td rowspan="1" colspan="1">HAMD-17</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.103</td><td rowspan="1" colspan="1">0.204</td><td rowspan="1" colspan="1">−0.066</td><td rowspan="1" colspan="1">−0.025</td></tr><tr><td rowspan="1" colspan="1">HAMA-14</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">−0.148</td><td rowspan="1" colspan="1">−0.007</td><td rowspan="1" colspan="1">−0.023</td><td rowspan="1" colspan="1">−0.176</td></tr><tr><td rowspan="2" colspan="1">Stepwise linear regression (<italic>β</italic>)</td><td rowspan="1" colspan="1">HAMD-17</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.344*</td><td rowspan="1" colspan="1">0.507**</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HAMA-14</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.796**</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: </citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither">Partial correlation analysis, controlling for the factors sex, PSQI score, and AIS score. *</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05, **</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01.</citation_analysis></p></fn><fn id="tfn0006"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: HAMD-17, 17-item Hamilton Depression Rating Scale; HAMA-14, 14-item Hamilton Anxiety Rating Scale; TNF-α, tumor necrosis factor-α; RANTES, regulated on activation and normal T cell expressed and presumably secreted; SAA, serum amyloid protein A; GM-CSF, granulocyte-macrophage colony-stimulating factor; PSQI, Pittsburgh Sleep Quality Index; AIS, Athens Insomnia Scale.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0003-s2004">
        <title>Correlations of RANTES, SAA, GM-CSF, and TNF-α with Sleep Quality/Insomnia Severity</title>
        <p><citation_analysis attribute="neither">In the Spearman correlation analyses, sex, HAMD-17 score, HAMA-14 score, and the serum levels of SAA and GM-CSF were positively correlated with the PSQI and AIS scores (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05). After controlling for sex, HAMD-17, and HAMA-14 scores, the partial correlation analyses showed that the serum level of GM-CSF was positively correlated with the PSQI score (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05). Furthermore, stepwise linear regression showed that PSQI and AIS scores were positively associated with HAMD-17 and HAMA-14 scores and GM-CSF and negatively associated with RANTES (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05). AIS score was also positively associated with SAA (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05, see </citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4</label><caption><p><citation_analysis attribute="neither">Correlations of RANTES, SAA, GM-CSF, and TNF-α with Insomnia</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Analysis</th><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">Sex</th><th rowspan="1" colspan="1">Age</th><th rowspan="1" colspan="1">Education</th><th rowspan="1" colspan="1">HAMD-17</th><th rowspan="1" colspan="1">HAMA-14</th><th rowspan="1" colspan="1">TNF-α</th><th rowspan="1" colspan="1">RANTES</th><th rowspan="1" colspan="1">SAA</th><th rowspan="1" colspan="1">GM-CSF</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">Spearman correlation (<italic>r</italic>)</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">0.180</td><td rowspan="1" colspan="1">0.120</td><td rowspan="1" colspan="1">–0.147</td><td rowspan="1" colspan="1">0.795**</td><td rowspan="1" colspan="1">0.770**</td><td rowspan="1" colspan="1">0.184</td><td rowspan="1" colspan="1">–0.135</td><td rowspan="1" colspan="1">0.282**</td><td rowspan="1" colspan="1">0.297**</td></tr><tr><td rowspan="1" colspan="1">AIS</td><td rowspan="1" colspan="1">0.238*</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1">–0.160</td><td rowspan="1" colspan="1">0.800**</td><td rowspan="1" colspan="1">0.847**</td><td rowspan="1" colspan="1">0.169</td><td rowspan="1" colspan="1">–0.125</td><td rowspan="1" colspan="1">0.398**</td><td rowspan="1" colspan="1">0.331**</td></tr><tr><td rowspan="2" colspan="1">Partial correlation (<italic>r</italic>)<sup>a</sup></td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.118</td><td rowspan="1" colspan="1">–0.183</td><td rowspan="1" colspan="1">0.203</td><td rowspan="1" colspan="1">0.268*</td></tr><tr><td rowspan="1" colspan="1">AIS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.086</td><td rowspan="1" colspan="1">–0.202</td><td rowspan="1" colspan="1">0.282**</td><td rowspan="1" colspan="1">0.285**</td></tr><tr><td rowspan="2" colspan="1">Stepwise linear regression (<italic>β</italic>)</td><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.536**</td><td rowspan="1" colspan="1">0.228*</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">–0.159**</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.184**</td></tr><tr><td rowspan="1" colspan="1">AIS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.180**</td><td rowspan="1" colspan="1">0.322**</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">–0.165**</td><td rowspan="1" colspan="1">0.138*</td><td rowspan="1" colspan="1">0.172**</td></tr></tbody></table><table-wrap-foot><fn id="tfn0007"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: </citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither">Partial correlation analysis, controlling for sex, HAMD-17 score, and HAMA-14 score. *</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05; **</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01.</citation_analysis></p></fn><fn id="tfn0008"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: PSQI, Pittsburgh Sleep Quality Index; AIS, Athens Insomnia Scale; HAMD-17, 17-item Hamilton Depression Rating Scale; HAMA-14, 14-item Hamilton Anxiety Rating Scale; TNF-α, tumor necrosis factor-α; RANTES, regulated on activation and normal T cell expressed and presumably secreted; SAA, serum amyloid protein A; GM-CSF, granulocyte-macrophage colony stimulating factor.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0003-s2005">
        <title>Potential Blood Biomarkers of CID Based on Receiver Operating Characteristic (ROC) Curve Analyses</title>
        <p><citation_analysis attribute="positive">Regarding the ROC curve analyses, the sensitivity, specificity, and area under the curve (AUC) values are shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0005" ref-type="table">Table 5</xref></citation_analysis><citation_analysis attribute="neither">. The AUCs of TNF-α, RANTES, SAA, and GM-CSF for differentiating between CID and GS were all &gt; 0.60. The optimal cut-off values were 367.12 pg/mL, 3.81 ng/mL, 52.09 g/mL, and 133.46 pg/mL, respectively.</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0005" orientation="portrait" position="float"><label>Table 5</label><caption><p><citation_analysis attribute="neither">ROC Curve Analysis Results Regarding Potential Blood Biomarkers of CID</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">AUC (95% CI)</th><th rowspan="1" colspan="1">Cut-Off</th><th rowspan="1" colspan="1">Sensitivity</th><th rowspan="1" colspan="1">Specificity</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">TNF-α</td><td rowspan="1" colspan="1">≥ 0.663 (0.551–0.775)**</td><td rowspan="1" colspan="1">367.12 pg/mL</td><td rowspan="1" colspan="1">0.554</td><td rowspan="1" colspan="1">0.743</td></tr><tr><td rowspan="1" colspan="1">RANTES</td><td rowspan="1" colspan="1">≤ 0.624 (0.498–0.750)*</td><td rowspan="1" colspan="1">3.81 ng/mL</td><td rowspan="1" colspan="1">0.821</td><td rowspan="1" colspan="1">0.257</td></tr><tr><td rowspan="1" colspan="1">SAA</td><td rowspan="1" colspan="1">≥ 0.761 (0.664–0.858)**</td><td rowspan="1" colspan="1">52.09 ng/mL</td><td rowspan="1" colspan="1">0.536</td><td rowspan="1" colspan="1">0.914</td></tr><tr><td rowspan="1" colspan="1">GM-CSF</td><td rowspan="1" colspan="1">≥ 0.761 (0.657–0.865)**</td><td rowspan="1" colspan="1">133.46 pg/mL</td><td rowspan="1" colspan="1">0.714</td><td rowspan="1" colspan="1">0.743</td></tr></tbody></table><table-wrap-foot><fn id="tfn0009"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: *</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05, **</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.01. </citation_analysis><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> ROC, receiver operating characteristic; AUC, area under the curve; CID, chronic insomnia disorder; TNF-α, tumor necrosis factor-α; RANTES, regulated on activation and normal T cell expressed and presumably secreted; SAA, serum amyloid protein A; GM-CSF, granulocyte-macrophage colony stimulating factor.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <sec id="s0004-s2001">
        <title>These Inflammatory Factors Were Altered in Patients with CID</title>
        <p><citation_analysis attribute="positive">This study examined the associations between insomnia and a range of inflammatory biomarkers in a cohort of 65 CID patients and 39 GS controls. We found that the levels of inflammatory mediators (SAA, TNF-α, and GM-CSF) in the CID patients were significantly elevated, while RANTES was significantly lower than in GS controls. Higher serum SAA and GM-CSF levels were significantly associated with higher total scores on the PSQI and AIS.</citation_analysis></p>
        <p><citation_analysis attribute="positive">Previous studies have shown there was a strong relationship between inflammatory cytokines and depression and anxiety. For example, there was an increase in serum levels of TNF-α, IL-6, IL-13, IL-18, IL-12, IL-1RA, sTNFR2, CCL2 (MCP-1), CXCL4, and CXCL7, and a decrease in IFN-γ and CCL4 in people suffering from depression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="positive"> It has been well established that a significant proportion of patients with anxiety-related disorders exhibit evidence of elevated inflammatory markers, including increases in cerebrospinal fluid and blood concentrations of inflammatory cytokines and acute-phase reactants, such as IL-1, IL-6, TNFs and their soluble receptors, and C-reactive protein.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> In the current study, we found that the CID patients had not only higher levels of SAA, TNF-α and GM-CSF, and lower levels of RANTES (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">) but also higher levels if depression and anxiety (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">). Moreover, the Spearman correlation showed that the serum levels were positively correlated with both depressive and anxious scores in SAA and GM-CSF, and with depressive scores in TNF-α (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="positive">). These findings appeared to suggest that the changed levels of detected inflammatory cytokines are the results from changed emotional states, at least partially. However, our data from Partial correlation and Stepwise linear regression indicated that the internal connection with SAA, GM-CSF, RANTES only occurred in insomnia but not in emotion (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Tables 3</xref></citation_analysis><citation_analysis attribute="neither"> and </citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">4</xref></citation_analysis><citation_analysis attribute="positive">). The cause might be that the severity of depression and anxiety was too mild to result in alteration of immune states.</citation_analysis></p>
        <p><citation_analysis attribute="positive">Why did SAA exhibit robust associations with insomnia severity in our study? SAA is a powerful proinflammatory regulator, reciprocally interacting with multiple aspects of the inflammatory cascade.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither"> It binds to and activates multiple structurally diverse receptors that mediate inflammation, including Toll-like receptors 2 and 4 (TLR2/TLR4), formyl peptide receptor-like 1 (FPRL1), and receptor for advanced glycation end products (RAGE).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="positive"> Through activation of these receptors, SAA has been shown to induce the secretion of the proinflammatory cytokines TNF-α, IL-6, IL-8, IL-23, and IL-18 and of the anti-inflammatory cytokine IL-10 in monocytes, macrophages, neutrophils, and fibroblasts. In addition, SAA is able to induce the secretion of mature IL-1β by providing the two signals needed for its production: binding to TLR2/TLR4 and activation of the NLR family pyrin domain-containing 3 (NLRP3) inflammasome in macrophages, dendritic cells, neutrophils, and mast cells. It is important to highlight that a growing body of the literature has evaluated the associations between elevated levels of IL-6, IL-1β, and TNF-α in people with insomnia symptoms, with slightly varying findings.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17–20</xref></citation_analysis><citation_analysis attribute="neither"> Other reports found that two nights of total sleep deprivation increased SAA, which may be related to the onset of subclinical inflammation, weight gain, and insulin resistance in both mice and humans.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="positive"> This increase may be due to increased SAA production or reduced SAA clearance. In short, most of the previous studies involved artificial sleep restriction under experimental conditions or people with insomnia symptoms but without a diagnosis of CID. Our study, for the first time, found an elevated serum level of SAA in CID patients in a natural state. SAA has been suggested to play a role in obesity and insulin resistance.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither"> In addition, an elevated serum level of SAA is an independent and strong predictor of coronary artery disease and adverse cardiovascular outcomes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="positive"> Our findings may improve the understanding of the signaling linking CID to its associated comorbidities, such as obesity, type 2 diabetes, and cardiovascular disease.</citation_analysis></p>
        <p><citation_analysis attribute="positive">It is currently not known whether the SAA in the peripheral circulation can cross the blood–brain barrier (BBB) and enter the central nervous system. Peripheral inflammation can increase BBB permeability, so it is possible that peripherally produced SAA may influence the development of insomnia symptoms either by crossing the BBB itself or by inducing other inflammatory factors that then may cross the BBB. To investigate the role of SAA in the brain, Yu et al examined the effects of recombinant human SAA on primary cultures of microglia and astrocytes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither"> They found that SAA was able to stimulate the production of IL-6, TNF-α, and other cytokines in microglia and astrocytes. SAA reduced the viability of astrocytes by inducing G1 cell cycle arrest. In addition, our previous study showed that CID patients had significantly increased serum levels of astrocyte biomarkers and we speculated that CID patients may have pathological changes in their astrocytes.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> It is therefore possible that SAA, produced in the central or peripheral nervous system, could influence the development of insomnia symptoms by activating microglial cells and inducing proinflammatory cytokine production. It is important to note that this study only cross-sectionally investigated the levels of potential biomarkers in CID patients. It is therefore not possible to draw any conclusions based on this study as to whether SAA is causally involved in the pathogenesis of CID.</citation_analysis></p>
        <p><citation_analysis attribute="positive">This study demonstrated that the level of TNF-α, which is a proinflammatory cytokine, increased in CID patients. The enhanced TNF-α in the CID patients at least partially stems from increased SAA, as SAA can upregulate several proinflammatory cytokines, including IL-1β, IL-6, IL-8, and TNF-α.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="positive"> TNF plays a role in sleep regulation and its sleep-related effectors and actions. Substantial evidence from young healthy animals indicates that acute enhancement or inhibition of endogenous brain TNF promotes or inhibits sleep, respectively.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45–47</xref></citation_analysis><citation_analysis attribute="positive"> Research has shown that TNF-α can improve non-rapid eye movement sleep,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0048" ref-type="bibr">48</xref></citation_analysis><citation_analysis attribute="neither"> while the inhibition of TNF-α reduces spontaneous sleep. In addition, TNF-α is considered part of a larger biochemical cascade involved in sleep regulation; other somnogenic substances in this cascade include growth hormone-releasing hormone and nitric oxide.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis><citation_analysis attribute="neither"> Notably, in most human studies on TNF and sleep, pathological conditions have been found to be associated with chronic elevations of systemic TNF and disrupted sleep. The chronic sleep disruption and shortening of sleep duration that occur in insomnia patients suggest that the chronicity of sleep loss across weeks or even years is an important factor in altering circulating TNF-α levels.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither"> Further research is needed to determine the changes in TNF levels in patients with different degrees and subtypes of insomnia.</citation_analysis></p>
        <p><citation_analysis attribute="neither">GM-CSF is a hematopoietic cytokine that may affect various functions of the central nervous system, as the molecule and its receptors are expressed in the brain.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="positive"> We assessed the GM-CSF levels in CID patients for the first time, and we found that insomnia patients had significantly higher GM-CSF than GS controls, and GM-CSF positively correlated with the severity of insomnia. GM-CSF is not a proinflammatory cytokine produced immediately after the onset of infection or inflammation. Rather, it is induced as a result of the proinflammatory cytokine activation cascade, involving somnogenic IL-1</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0052" ref-type="bibr">52</xref></citation_analysis><citation_analysis attribute="neither"> and TNF-α.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0053" ref-type="bibr">53</xref></citation_analysis><citation_analysis attribute="neither"> SAA can also upregulate GM-CSF.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither"> The human body is a complex physiological entity, with various inflammatory factors influencing each other. The chronic process of insomnia is an important factor leading to changes in the levels of many circulating cytokines.</citation_analysis></p>
        <p><citation_analysis attribute="neither">RANTES is classified as a chemokine and is a chemoattractant of T cells, eosinophils, and basophils, recruiting leukocytes into inflammatory sites.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0054" ref-type="bibr">54</xref></citation_analysis><citation_analysis attribute="neither"> Apart from its widely known role in human immunodeficiency virus infection, RANTES plays a role in inflammation in patients with obstructive sleep apnea,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0055" ref-type="bibr">55</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0056" ref-type="bibr">56</xref></citation_analysis><citation_analysis attribute="positive"> which manifests as a positive association between RANTES and Apnea–Hypopnea Index (AHI) in adults. A recent study found that sleep deprivation was associated with a potential decrease in the RANTES/CXCL9 ratio, which is related to changes in the Th1-related chemokine balance.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0057" ref-type="bibr">57</xref></citation_analysis><citation_analysis attribute="neither"> Our study, for the first time, detected the serum level of RANTES in CID patients and found that it was negatively correlated with the severity of insomnia.</citation_analysis></p>
      </sec>
      <sec id="s0004-s2002">
        <title>The Possible Diagnostic and Prognostic Value of These Inflammatory Biomarkers</title>
        <p><citation_analysis attribute="positive">ROC analysis was used to calculate the cut-off values of different inflammatory biomarkers to discriminate between true and false CID diagnosis as established by the ICSD-3 criteria. The results showed that the AUCs of all four inflammatory biomarkers were over 0.6 between patients with CID and GS. The optimal cut-off values for TNF-α, SAA and GM-CSF indicated that subjects should be considered to have CID if their inflammatory biomarkers levels were above the corresponding cut-off values. The optimal cut-off values for RANTES indicated that subjects should be considered to have CID if their inflammatory biomarkers levels were lower than the corresponding cut-off values. These results might provide strong cues for considering CID relative to healthy sleep, implying the possibility that these serum indexes act as objective diagnostic markers for CID. Combining these four indicators may provide a more specific and sensitive method to better manage and offer more accurate prognosis of patients with CID.</citation_analysis></p>
      </sec>
      <sec id="s0004-s2003">
        <title>Limitations</title>
        <p><citation_analysis attribute="positive">There are several limitations in this study. The inflammatory factors were only measured at initial presentation rather than being tracked during the treatment of insomnia. Additionally, this study is an exploratory analysis based on a relatively small sample. The limited statistical power due to the sample size means that we cannot accurately determine the different contributions of each inflammatory factor to insomnia. In future research, a larger sample size is needed to increase the statistical power. Finally, our analysis was limited to the serum levels of the inflammatory factors, and we were unable to assess the association between the inflammatory factors and complications caused by insomnia. The study findings should motivate further investigations into the inflammatory mechanisms underlying the effects of CID, which will have implications for cardiovascular and other chronic inflammatory disorders in insomnia patients.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0005">
      <title>Conclusions</title>
      <p><citation_analysis attribute="neither">In summary, our data showed that the levels of inflammatory mediators (SAA, TNF-α, and GM-CSF) were significantly elevated, while the level of RANTES decreased in CID patients and, to some extent, these changes are related to the severity of insomnia. In the future, we can verify the roles of these inflammatory mediators (SAA, TNF-α, GM-CSF, and RANTES) in the mechanism of insomnia by animal experiments, and find the interventions of preventing the biological consequences of CID by inhibiting inflammation. As a result, the health of insomnia will be improved.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">We would like to thank the Neurology (Sleep Disorders), the Affiliated Chaohu Hospital of Anhui Medical University for their support during data collection. Gong Chen and Gui-Hai Chen are co-correspondence authors for this study.</citation_analysis></p>
    </ack>
    <sec id="s0006" sec-type="COI-statement">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors have indicated no conflicts of interest.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chung</surname><given-names>KF</given-names></string-name>, <string-name><surname>Yeung</surname><given-names>WF</given-names></string-name>, <string-name><surname>Ho</surname><given-names>FY</given-names></string-name>, <string-name><surname>Yung</surname><given-names>KP</given-names></string-name>, <string-name><surname>Yu</surname><given-names>YM</given-names></string-name>, <string-name><surname>Kwok</surname><given-names>CW</given-names></string-name>. <article-title>Cross-cultural and comparative epidemiology of insomnia: the diagnostic and statistical manual (DSM), international classification of diseases (ICD) and international classification of sleep disorders (ICSD)</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2015</year>;<volume>16</volume>(<issue>4</issue>):<fpage>477</fpage>–<lpage>482</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2014.10.018</pub-id><pub-id pub-id-type="pmid">25761665</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Baglioni</surname><given-names>C</given-names></string-name>, <string-name><surname>Battagliese</surname><given-names>G</given-names></string-name>, <string-name><surname>Feige</surname><given-names>B</given-names></string-name>, et al. <article-title>Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies</article-title>. <source><italic toggle="yes">J Affect Disord</italic></source>. <year>2011</year>;<volume>135</volume>(<issue>1–3</issue>):<fpage>10</fpage>–<lpage>19</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2011.01.011</pub-id><pub-id pub-id-type="pmid">21300408</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Riemann</surname><given-names>D</given-names></string-name>, <string-name><surname>Voderholzer</surname><given-names>U</given-names></string-name>. <article-title>Primary insomnia: a risk factor to develop depression?</article-title><source><italic toggle="yes">J Affect Disord</italic></source>. <year>2003</year>;<volume>76</volume>(<issue>1–3</issue>):<fpage>255</fpage>–<lpage>259</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0165-0327(02)00072-1</pub-id><pub-id pub-id-type="pmid">12943956</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Palagini</surname><given-names>L</given-names></string-name>, <string-name><surname>Bruno</surname><given-names>RM</given-names></string-name>, <string-name><surname>Gemignani</surname><given-names>A</given-names></string-name>, <string-name><surname>Baglioni</surname><given-names>C</given-names></string-name>, <string-name><surname>Ghiadoni</surname><given-names>L</given-names></string-name>, <string-name><surname>Riemann</surname><given-names>D</given-names></string-name>. <article-title>Sleep loss and hypertension: a systematic review</article-title>. <source><italic toggle="yes">Curr Pharm Des</italic></source>. <year>2013</year>;<volume>19</volume>(<issue>13</issue>):<fpage>2409</fpage>–<lpage>2419</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1381612811319130009</pub-id><pub-id pub-id-type="pmid">23173590</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Vgontzas</surname><given-names>AN</given-names></string-name>, <string-name><surname>Fernandez-Mendoza</surname><given-names>J</given-names></string-name>, <string-name><surname>Liao</surname><given-names>D</given-names></string-name>, <string-name><surname>Bixler</surname><given-names>EO</given-names></string-name>. <article-title>Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2013</year>;<volume>17</volume>(<issue>4</issue>):<fpage>241</fpage>–<lpage>254</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2012.09.005</pub-id><pub-id pub-id-type="pmid">23419741</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shi</surname><given-names>T</given-names></string-name>, <string-name><surname>Min</surname><given-names>M</given-names></string-name>, <string-name><surname>Sun</surname><given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Liang</surname><given-names>M</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y</given-names></string-name>. <article-title>Does insomnia predict a high risk of cancer? A systematic review and meta-analysis of cohort studies</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2020</year>;<volume>29</volume>(<issue>1</issue>):<fpage>e12876</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.12876</pub-id><pub-id pub-id-type="pmid">31352687</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nixon</surname><given-names>JP</given-names></string-name>, <string-name><surname>Mavanji</surname><given-names>V</given-names></string-name>, <string-name><surname>Butterick</surname><given-names>TA</given-names></string-name>, <string-name><surname>Billington</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Kotz</surname><given-names>CM</given-names></string-name>, <string-name><surname>Teske</surname><given-names>JA</given-names></string-name>. <article-title>Sleep disorders, obesity, and aging: the role of orexin</article-title>. <source><italic toggle="yes">Ageing Res Rev</italic></source>. <year>2015</year>;<volume>20</volume>:<fpage>63</fpage>–<lpage>73</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arr.2014.11.001</pub-id><pub-id pub-id-type="pmid">25462194</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Johansson</surname><given-names>M</given-names></string-name>, <string-name><surname>Jansson-Fröjmark</surname><given-names>M</given-names></string-name>, <string-name><surname>Norell-Clarke</surname><given-names>A</given-names></string-name>, <string-name><surname>Linton</surname><given-names>SJ</given-names></string-name>. <article-title>The role of psychiatric and somatic conditions in incidence and persistence of insomnia: a longitudinal, community study</article-title>. <source><italic toggle="yes">Sleep Health</italic></source>. <year>2016</year>;<volume>2</volume>(<issue>3</issue>):<fpage>229</fpage>–<lpage>238</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleh.2016.05.004</pub-id><pub-id pub-id-type="pmid">29073427</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hsieh</surname><given-names>CG</given-names></string-name>, <string-name><surname>Martin</surname><given-names>JL</given-names></string-name>. <article-title>Short sleep, insomnia, and cardiovascular disease</article-title>. <source><italic toggle="yes">Curr Sleep Med Rep</italic></source>. <year>2019</year>;<volume>5</volume>(<issue>4</issue>):<fpage>234</fpage>–<lpage>242</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40675-019-00157-8</pub-id><pub-id pub-id-type="pmid">33344144</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Thomas</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Calhoun</surname><given-names>D</given-names></string-name>. <article-title>Sleep, insomnia, and hypertension: current findings and future directions</article-title>. <source><italic toggle="yes">J Am Soc Hypertens</italic></source>. <year>2017</year>;<volume>11</volume>(<issue>2</issue>):<fpage>122</fpage>–<lpage>129</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jash.2016.11.008</pub-id><pub-id pub-id-type="pmid">28109722</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Patel</surname><given-names>SR</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>X</given-names></string-name>, <string-name><surname>Storfer-Isser</surname><given-names>A</given-names></string-name>, et al. <article-title>Sleep duration and biomarkers of inflammation</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2009</year>;<volume>32</volume>(<issue>2</issue>):<fpage>200</fpage>–<lpage>204</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/32.2.200</pub-id><pub-id pub-id-type="pmid">19238807</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Matthews</surname><given-names>KA</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>H</given-names></string-name>, <string-name><surname>Kravitz</surname><given-names>HM</given-names></string-name>, et al. <article-title>Are inflammatory and coagulation biomarkers related to sleep characteristics in mid-life women? Study of women’s health across the Nation Sleep Study</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2010</year>;<volume>33</volume>(<issue>12</issue>):<fpage>1649</fpage>–<lpage>1655</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/33.12.1649</pub-id><pub-id pub-id-type="pmid">21120127</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hale</surname><given-names>L</given-names></string-name>, <string-name><surname>Parente</surname><given-names>V</given-names></string-name>, <string-name><surname>Dowd</surname><given-names>JB</given-names></string-name>, et al. <article-title>Fibrinogen may mediate the association between long sleep duration and coronary heart disease</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2013</year>;<volume>22</volume>(<issue>3</issue>):<fpage>305</fpage>–<lpage>314</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.12020</pub-id><pub-id pub-id-type="pmid">23217092</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Irwin</surname><given-names>MR</given-names></string-name>, <string-name><surname>Olmstead</surname><given-names>R</given-names></string-name>, <string-name><surname>Carroll</surname><given-names>JE</given-names></string-name>. <article-title>Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation</article-title>. <source><italic toggle="yes">Biol Psychiatry</italic></source>. <year>2016</year>;<volume>80</volume>(<issue>1</issue>):<fpage>40</fpage>–<lpage>52</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2015.05.014</pub-id><pub-id pub-id-type="pmid">26140821</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Slavish</surname><given-names>DC</given-names></string-name>, <string-name><surname>Graham-Engeland</surname><given-names>JE</given-names></string-name>, <string-name><surname>Engeland</surname><given-names>CG</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Buxton</surname><given-names>OM</given-names></string-name>. <article-title>Insomnia symptoms are associated with elevated C-reactive protein in young adults</article-title>. <source><italic toggle="yes">Psychol Health</italic></source>. <year>2018</year>;<volume>33</volume>(<issue>11</issue>):<fpage>1396</fpage>–<lpage>1415</lpage>. doi:<pub-id pub-id-type="doi">10.1080/08870446.2018.1500577</pub-id><pub-id pub-id-type="pmid">30358412</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fernandez-Mendoza</surname><given-names>J</given-names></string-name>, <string-name><surname>Baker</surname><given-names>JH</given-names></string-name>, <string-name><surname>Vgontzas</surname><given-names>AN</given-names></string-name>, <string-name><surname>Gaines</surname><given-names>J</given-names></string-name>, <string-name><surname>Liao</surname><given-names>D</given-names></string-name>, <string-name><surname>Bixler</surname><given-names>EO</given-names></string-name>. <article-title>Insomnia symptoms with objective short sleep duration are associated with systemic inflammation in adolescents</article-title>. <source><italic toggle="yes">Brain Behav Immun</italic></source>. <year>2017</year>;<volume>61</volume>:<fpage>110</fpage>–<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2016.12.026</pub-id><pub-id pub-id-type="pmid">28041986</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Satyanarayanan</surname><given-names>SK</given-names></string-name>, <string-name><surname>Chien</surname><given-names>YC</given-names></string-name>, <string-name><surname>Chang</surname><given-names>JP</given-names></string-name>, et al. <article-title>Melatonergic agonist regulates circadian clock genes and peripheral inflammatory and neuroplasticity markers in patients with depression and anxiety</article-title>. <source><italic toggle="yes">Brain Behav Immun</italic></source>. <year>2020</year>;<volume>85</volume>:<fpage>142</fpage>–<lpage>151</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2019.03.003</pub-id><pub-id pub-id-type="pmid">30851380</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name><surname>Yang</surname><given-names>G</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name><surname>Xu</surname><given-names>M</given-names></string-name>. <article-title>Effects of chronic intractable insomnia on inflammatory cytokines, blood pressure characteristics, and antihypertensive efficacy in hypertensive patients</article-title>. <source><italic toggle="yes">Med Sci Monit</italic></source>. <year>2018</year>;<volume>24</volume>:<fpage>9259</fpage>–<lpage>9264</lpage>. doi:<pub-id pub-id-type="doi">10.12659/MSM.911997</pub-id><pub-id pub-id-type="pmid">30568156</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rethorst</surname><given-names>CD</given-names></string-name>, <string-name><surname>Greer</surname><given-names>TL</given-names></string-name>, <string-name><surname>Toups</surname><given-names>MS</given-names></string-name>, <string-name><surname>Bernstein</surname><given-names>I</given-names></string-name>, <string-name><surname>Carmody</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Trivedi</surname><given-names>MH</given-names></string-name>. <article-title>IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder</article-title>. <source><italic toggle="yes">Transl Psychiatry</italic></source>. <year>2015</year>;<volume>5</volume>(<issue>8</issue>):<fpage>e611</fpage>. doi:<pub-id pub-id-type="doi">10.1038/tp.2015.104</pub-id><pub-id pub-id-type="pmid">26241349</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname><given-names>H</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wu</surname><given-names>H</given-names></string-name>, et al. <article-title>Relationship between serum IL-1β and insomnia and liver depression in patients with perimenopausal non-organic sleep disorder</article-title>. <source><italic toggle="yes">Exp Ther Med</italic></source>. <year>2019</year>;<volume>17</volume>(<issue>1</issue>):<fpage>759</fpage>–<lpage>763</lpage>. doi:<pub-id pub-id-type="doi">10.3892/etm.2018.6990</pub-id><pub-id pub-id-type="pmid">30651860</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bower</surname><given-names>JE</given-names></string-name>, <string-name><surname>Ganz</surname><given-names>PA</given-names></string-name>, <string-name><surname>Irwin</surname><given-names>MR</given-names></string-name>, <string-name><surname>Kwan</surname><given-names>L</given-names></string-name>, <string-name><surname>Breen</surname><given-names>EC</given-names></string-name>, <string-name><surname>Cole</surname><given-names>SW</given-names></string-name>. <article-title>Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?</article-title><source><italic toggle="yes">J Clin Oncol</italic></source>. <year>2011</year>;<volume>29</volume>(<issue>26</issue>):<fpage>3517</fpage>–<lpage>3522</lpage>. doi:<pub-id pub-id-type="doi">10.1200/JCO.2011.36.1154</pub-id><pub-id pub-id-type="pmid">21825266</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Walker</surname><given-names>JL</given-names></string-name>, <string-name><surname>Slavish</surname><given-names>DC</given-names></string-name>, <string-name><surname>Dolan</surname><given-names>M</given-names></string-name>, et al. <article-title>Age-dependent associations among insomnia, depression, and inflammation in nurses</article-title>. <source><italic toggle="yes">Psychol Health</italic></source>. <year>2020</year>:<fpage>1</fpage>–<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1080/08870446.2020.1805450</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shrihari</surname><given-names>TG</given-names></string-name>. <article-title>Dual role of inflammatory mediators in cancer</article-title>. <source><italic toggle="yes">Ecancermedicalscience</italic></source>. <year>2017</year>;<volume>11</volume>:<fpage>721</fpage>. doi:<pub-id pub-id-type="doi">10.3332/ecancer.2017.721</pub-id><pub-id pub-id-type="pmid">28275390</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hamilton</surname><given-names>JA</given-names></string-name>. <article-title>GM-CSF in inflammation</article-title>. <source><italic toggle="yes">J Exp Med</italic></source>. <year>2020</year>;<volume>217</volume>(<issue>1</issue>):<fpage>e20190945</fpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20190945</pub-id><pub-id pub-id-type="pmid">31611249</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lee</surname><given-names>KMC</given-names></string-name>, <string-name><surname>Achuthan</surname><given-names>AA</given-names></string-name>, <string-name><surname>Hamilton</surname><given-names>JA</given-names></string-name>. <article-title>GM-CSF: a promising target in inflammation and autoimmunity</article-title>. <source><italic toggle="yes">Immunotargets Ther</italic></source>. <year>2020</year>;<volume>9</volume>:<fpage>225</fpage>–<lpage>240</lpage>. doi:<pub-id pub-id-type="doi">10.2147/ITT.S262566</pub-id><pub-id pub-id-type="pmid">33150139</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Akoum</surname><given-names>A</given-names></string-name>, <string-name><surname>Lemay</surname><given-names>A</given-names></string-name>, <string-name><surname>Maheux</surname><given-names>R</given-names></string-name>. <article-title>Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2002</year>;<volume>87</volume>(<issue>12</issue>):<fpage>5785</fpage>–<lpage>5792</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2002-020106</pub-id><pub-id pub-id-type="pmid">12466387</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nonaka</surname><given-names>M</given-names></string-name>, <string-name><surname>Pawankar</surname><given-names>R</given-names></string-name>, <string-name><surname>Saji</surname><given-names>F</given-names></string-name>, <string-name><surname>Yagi</surname><given-names>T</given-names></string-name>. <article-title>Distinct expression of RANTES and GM-CSF by lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts</article-title>. <source><italic toggle="yes">Int Arch Allergy Immunol</italic></source>. <year>1999</year>;<volume>119</volume>(<issue>4</issue>):<fpage>314</fpage>–<lpage>321</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000024209</pub-id><pub-id pub-id-type="pmid">10474037</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gabay</surname><given-names>C</given-names></string-name>, <string-name><surname>Kushner</surname><given-names>I</given-names></string-name>. <article-title>Acute-phase proteins and other systemic responses to inflammation</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>1999</year>;<volume>340</volume>(<issue>6</issue>):<fpage>448</fpage>–<lpage>454</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJM199902113400607</pub-id><pub-id pub-id-type="pmid">9971870</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Migita</surname><given-names>K</given-names></string-name>, <string-name><surname>Koga</surname><given-names>T</given-names></string-name>, <string-name><surname>Satomura</surname><given-names>K</given-names></string-name>, et al. <article-title>Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts</article-title>. <source><italic toggle="yes">Arthritis Res Ther</italic></source>. <year>2012</year>;<volume>14</volume>(<issue>3</issue>):<fpage>R119</fpage>. doi:<pub-id pub-id-type="doi">10.1186/ar3849</pub-id><pub-id pub-id-type="pmid">22608202</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Eklund</surname><given-names>KK</given-names></string-name>, <string-name><surname>Niemi</surname><given-names>K</given-names></string-name>, <string-name><surname>Kovanen</surname><given-names>PT</given-names></string-name>. <article-title>Immune functions of serum amyloid A</article-title>. <source><italic toggle="yes">Crit Rev Immunol</italic></source>. <year>2012</year>;<volume>32</volume>(<issue>4</issue>):<fpage>335</fpage>–<lpage>348</lpage>. doi:<pub-id pub-id-type="doi">10.1615/CritRevImmunol.v32.i4.40</pub-id><pub-id pub-id-type="pmid">23237509</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Su</surname><given-names>X</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>X</given-names></string-name>, et al. <article-title>iTRAQ technology-based identification of human peripheral serum proteins associated with depression</article-title>. <source><italic toggle="yes">Neuroscience</italic></source>. <year>2016</year>;<volume>330</volume>:<fpage>291</fpage>–<lpage>325</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.05.055</pub-id><pub-id pub-id-type="pmid">27268281</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Morin</surname><given-names>CM</given-names></string-name>, <string-name><surname>Drake</surname><given-names>CL</given-names></string-name>, <string-name><surname>Harvey</surname><given-names>AG</given-names></string-name>, et al. <article-title>Insomnia disorder</article-title>. <source><italic toggle="yes">Nat Rev Dis Primers</italic></source>. <year>2015</year>;<volume>1</volume>(<issue>1</issue>):<fpage>15026</fpage>. doi:<pub-id pub-id-type="doi">10.1038/nrdp.2015.26</pub-id><pub-id pub-id-type="pmid">27189779</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Buysse</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Reynolds</surname><given-names>CF</given-names><suffix>3rd</suffix></string-name>, <string-name><surname>Monk</surname><given-names>TH</given-names></string-name>, <string-name><surname>Berman</surname><given-names>SR</given-names></string-name>, <string-name><surname>Kupfer</surname><given-names>DJ</given-names></string-name>. <article-title>The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research</article-title>. <source><italic toggle="yes">Psychiatry Res</italic></source>. <year>1989</year>;<volume>28</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>213</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0165-1781(89)90047-4</pub-id><pub-id pub-id-type="pmid">2748771</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mollayeva</surname><given-names>T</given-names></string-name>, <string-name><surname>Thurairajah</surname><given-names>P</given-names></string-name>, <string-name><surname>Burton</surname><given-names>K</given-names></string-name>, <string-name><surname>Mollayeva</surname><given-names>S</given-names></string-name>, <string-name><surname>Shapiro</surname><given-names>CM</given-names></string-name>, <string-name><surname>Colantonio</surname><given-names>A</given-names></string-name>. <article-title>The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2016</year>;<volume>25</volume>:<fpage>52</fpage>–<lpage>73</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2015.01.009</pub-id><pub-id pub-id-type="pmid">26163057</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Soldatos</surname><given-names>CR</given-names></string-name>, <string-name><surname>Dikeos</surname><given-names>DG</given-names></string-name>, <string-name><surname>Paparrigopoulos</surname><given-names>TJ</given-names></string-name>. <article-title>Athens insomnia scale: validation of an instrument based on ICD-10 criteria</article-title>. <source><italic toggle="yes">J Psychosom Res</italic></source>. <year>2000</year>;<volume>48</volume>(<issue>6</issue>):<fpage>555</fpage>–<lpage>560</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0022-3999(00)00095-7</pub-id><pub-id pub-id-type="pmid">11033374</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lee</surname><given-names>CH</given-names></string-name>, <string-name><surname>Giuliani</surname><given-names>F</given-names></string-name>. <article-title>The role of inflammation in depression and fatigue</article-title>. <source><italic toggle="yes">Front Immunol</italic></source>. <year>2019</year>;<volume>10</volume>:<fpage>1696</fpage>. <comment>eCollection 2019</comment>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.01696</pub-id><pub-id pub-id-type="pmid">31379879</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jennifer</surname><given-names>CF</given-names></string-name>. <article-title>Imaging the role of inflammation in mood and anxiety-related disorders</article-title>. <source><italic toggle="yes">Curr Neuropharmacol</italic></source>. <year>2018</year>;<volume>16</volume>(<issue>5</issue>):<fpage>533</fpage>–<lpage>558</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1570159X15666171123201142</pub-id><pub-id pub-id-type="pmid">29173175</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sack</surname><given-names>GH</given-names><suffix>Jr.</suffix></string-name><article-title>Serum amyloid A (SAA) proteins</article-title>. <source><italic toggle="yes">Subcell Biochem</italic></source>. <year>2020</year>;<volume>94</volume>:<fpage>421</fpage>–<lpage>436</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-3-030-41769-7_17</pub-id><pub-id pub-id-type="pmid">32189310</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Sheng</surname><given-names>H</given-names></string-name>, <string-name><surname>Li</surname><given-names>H</given-names></string-name>, <string-name><surname>Wang</surname><given-names>R</given-names></string-name>. <article-title>Acute phase reactant serum amyloid A in inflammation and other diseases</article-title>. <source><italic toggle="yes">Adv Clin Chem</italic></source>. <year>2019</year>;<volume>90</volume>:<fpage>25</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">31122611</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>de Oliveira</surname><given-names>EM</given-names></string-name>, <string-name><surname>Visniauskas</surname><given-names>B</given-names></string-name>, <string-name><surname>Tufik</surname><given-names>S</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>ML</given-names></string-name>, <string-name><surname>Chagas</surname><given-names>JR</given-names></string-name>, <string-name><surname>Campa</surname><given-names>A</given-names></string-name>. <article-title>Serum amyloid A production is triggered by sleep deprivation in mice and humans: is that the link between sleep loss and associated comorbidities?</article-title><source><italic toggle="yes">Nutrients</italic></source>. <year>2017</year>;<volume>9</volume>(<issue>3</issue>):<fpage>311</fpage>. doi:<pub-id pub-id-type="doi">10.3390/nu9030311</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name><surname>Li</surname><given-names>SQ</given-names></string-name>, <string-name><surname>Peng</surname><given-names>L</given-names></string-name>, <string-name><surname>Ye</surname><given-names>RD</given-names></string-name>. <article-title>Serum amyloid a differentially activates microglia and astrocytes via the PI3K pathway</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2014</year>;<volume>38</volume>:<fpage>133</fpage>–<lpage>144</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-130818</pub-id><pub-id pub-id-type="pmid">23948927</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname><given-names>P</given-names></string-name>, <string-name><surname>Tan</surname><given-names>CW</given-names></string-name>, <string-name><surname>Chen</surname><given-names>GH</given-names></string-name>, et al. <article-title>Patients with chronic insomnia disorder have increased serum levels of neurofilaments, neuron-specific enolase and S100B: does organic brain damage exist?</article-title><source><italic toggle="yes">Sleep Med</italic></source>. <year>2018</year>;<volume>48</volume>:<fpage>163</fpage>–<lpage>171</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2017.12.012</pub-id><pub-id pub-id-type="pmid">29957487</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname><given-names>P</given-names></string-name>, <string-name><surname>Li</surname><given-names>YX</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>ZZ</given-names></string-name>, et al. <article-title>Astroglial mechanisms underlying chronic insomnia disorder: a Clinical Study</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2020</year>;<volume>12</volume>:<fpage>693</fpage>–<lpage>704</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S263528</pub-id><pub-id pub-id-type="pmid">33117005</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Song</surname><given-names>C</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>K</given-names></string-name>, <string-name><surname>Yamen</surname><given-names>E</given-names></string-name>, et al. <article-title>Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes</article-title>. <source><italic toggle="yes">Atherosclerosis</italic></source>. <year>2009</year>;<volume>207</volume>(<issue>2</issue>):<fpage>374</fpage>–<lpage>383</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2009.05.007</pub-id><pub-id pub-id-type="pmid">19535079</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Churchill</surname><given-names>L</given-names></string-name>, <string-name><surname>Rector</surname><given-names>DM</given-names></string-name>, <string-name><surname>Yasuda</surname><given-names>K</given-names></string-name>, et al. <article-title>Tumor necrosis factor alpha: activity dependent expression and promotion of cortical column sleep in rats</article-title>. <source><italic toggle="yes">Front Immunol</italic></source>. <year>2019</year>;<volume>10</volume>:<fpage>1696</fpage>.<pub-id pub-id-type="pmid">31379879</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jewett</surname><given-names>KA</given-names></string-name>, <string-name><surname>Taishi</surname><given-names>P</given-names></string-name>, <string-name><surname>Sengupta</surname><given-names>P</given-names></string-name>, <string-name><surname>Roy</surname><given-names>S</given-names></string-name>, <string-name><surname>Davis</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Krueger</surname><given-names>JM</given-names></string-name>. <article-title>Tumor necrosis factor enhances the sleep-like state and electrical stimulation induces a wake-like state in co-cultures of neurons and glia</article-title>. <source><italic toggle="yes">Eur J Neurosci</italic></source>. <year>2015</year>;<volume>42</volume>(<issue>4</issue>):<fpage>2078</fpage>–<lpage>2090</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ejn.12968</pub-id><pub-id pub-id-type="pmid">26036796</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Karrer</surname><given-names>M</given-names></string-name>, <string-name><surname>Lopez</surname><given-names>MA</given-names></string-name>, <string-name><surname>Meier</surname><given-names>D</given-names></string-name>, et al. <article-title>Cytokine-induced sleep: neurons respond to TNF with production of chemokines and increased expression of Homer1a in vitro</article-title>. <source><italic toggle="yes">Brain Behav Immun</italic></source>. <year>2015</year>;<volume>47</volume>:<fpage>186</fpage>–<lpage>192</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2014.11.008</pub-id><pub-id pub-id-type="pmid">25476601</pub-id></mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shoham</surname><given-names>S</given-names></string-name>, <string-name><surname>Davenne</surname><given-names>D</given-names></string-name>, <string-name><surname>Cady</surname><given-names>AB</given-names></string-name>, <string-name><surname>Dinarello</surname><given-names>CA</given-names></string-name>, <string-name><surname>Krueger</surname><given-names>JM</given-names></string-name>. <article-title>Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep</article-title>. <source><italic toggle="yes">Am J Physiol</italic></source>. <year>1987</year>;<volume>253</volume>(<issue>1 Pt 2</issue>):<fpage>R142</fpage>–<lpage>R149</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpregu.1987.253.1.R142</pub-id><pub-id pub-id-type="pmid">3496800</pub-id></mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Krueger</surname><given-names>JM</given-names></string-name>, <string-name><surname>Fang</surname><given-names>J</given-names></string-name>, <string-name><surname>Taishi</surname><given-names>P</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name><surname>Kushikata</surname><given-names>T</given-names></string-name>, <string-name><surname>Gardi</surname><given-names>J</given-names></string-name>. <article-title>Sleep. A physiologic role for IL-1 beta and TNF-alpha</article-title>. <source><italic toggle="yes">Ann N Y Acad Sci</italic></source>. <year>1998</year>;<volume>856</volume>:<fpage>148</fpage>–<lpage>159</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1749-6632.1998.tb08323.x</pub-id><pub-id pub-id-type="pmid">9917875</pub-id></mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Haack</surname><given-names>M</given-names></string-name>, <string-name><surname>Pollmächer</surname><given-names>T</given-names></string-name>, <string-name><surname>Mullington</surname><given-names>JM</given-names></string-name>. <article-title>Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers</article-title>. <source><italic toggle="yes">Brain Behav Immun</italic></source>. <year>2004</year>;<volume>18</volume>(<issue>4</issue>):<fpage>361</fpage>–<lpage>367</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2003.12.009</pub-id><pub-id pub-id-type="pmid">15157953</pub-id></mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kimura</surname><given-names>M</given-names></string-name>, <string-name><surname>Kodama</surname><given-names>T</given-names></string-name>, <string-name><surname>Aguila</surname><given-names>MC</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>SQ</given-names></string-name>, <string-name><surname>Inoue</surname><given-names>S</given-names></string-name>. <article-title>Granulocyte-macrophage colony-stimulating factor modulates rapid eye movement (REM) sleep and non-REM sleep in rats</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2000</year>;<volume>20</volume>(<issue>14</issue>):<fpage>5544</fpage>–<lpage>5551</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-14-05544.2000</pub-id><pub-id pub-id-type="pmid">10884338</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Henricson</surname><given-names>BE</given-names></string-name>, <string-name><surname>Neta</surname><given-names>R</given-names></string-name>, <string-name><surname>Vogel</surname><given-names>SN</given-names></string-name>. <article-title>An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance</article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>1991</year>;<volume>59</volume>(<issue>3</issue>):<fpage>1188</fpage>–<lpage>1191</lpage>. doi:<pub-id pub-id-type="doi">10.1128/iai.59.3.1188-1191.1991</pub-id><pub-id pub-id-type="pmid">1825485</pub-id></mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Duru</surname><given-names>F</given-names></string-name>, <string-name><surname>Ertem</surname><given-names>U</given-names></string-name>, <string-name><surname>Taçyildiz</surname><given-names>N</given-names></string-name>, <string-name><surname>Kirazli</surname><given-names>S</given-names></string-name>. <article-title>Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia</article-title>. <source><italic toggle="yes">J Med</italic></source>. <year>1995</year>;<volume>26</volume>(<issue>5–6</issue>):<fpage>241</fpage>–<lpage>252</lpage>.<pub-id pub-id-type="pmid">8721901</pub-id></mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Arnaud</surname><given-names>C</given-names></string-name>, <string-name><surname>Beguin</surname><given-names>PC</given-names></string-name>, <string-name><surname>Lantuejoul</surname><given-names>S</given-names></string-name>, et al. <article-title>The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2011</year>;<volume>184</volume>(<issue>6</issue>):<fpage>724</fpage>–<lpage>731</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201012-2033OC</pub-id><pub-id pub-id-type="pmid">21680945</pub-id></mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chuang</surname><given-names>HH</given-names></string-name>, <string-name><surname>Huang</surname><given-names>CG</given-names></string-name>, <string-name><surname>Chuang</surname><given-names>LP</given-names></string-name>, et al. <article-title>Relationships among and predictive values of obesity, inflammation markers, and disease severity in pediatric patients with obstructive sleep apnea before and after adenotonsillectomy</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2020</year>;<volume>9</volume>(<issue>2</issue>):<fpage>579</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm9020579</pub-id></mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Testelmans</surname><given-names>D</given-names></string-name>, <string-name><surname>Tamisier</surname><given-names>R</given-names></string-name>, <string-name><surname>Barone-Rochette</surname><given-names>G</given-names></string-name>, et al. <article-title>Profile of circulating cytokines: impact of OSA, obesity and acute cardiovascular events</article-title>. <source><italic toggle="yes">Cytokine</italic></source>. <year>2013</year>;<volume>62</volume>(<issue>2</issue>):<fpage>210</fpage>–<lpage>216</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cyto.2013.02.021</pub-id><pub-id pub-id-type="pmid">23522821</pub-id></mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Said</surname><given-names>EA</given-names></string-name>, <string-name><surname>Al-Abri</surname><given-names>MA</given-names></string-name>, <string-name><surname>Al-Saidi</surname><given-names>I</given-names></string-name>, et al. <article-title>Sleep deprivation alters neutrophil functions and levels of Th1-related chemokines and CD<sup>4+</sup> T cells in the blood</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2019</year>;<volume>23</volume>(<issue>4</issue>):<fpage>1331</fpage>–<lpage>1339</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-019-018511</pub-id><pub-id pub-id-type="pmid">31041780</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
